LYN-005 is an investigational long-acting oral capsule formulation of the atypical antipsychotic risperidone. Positive data were announced from a phase 3 study comparing the pharmacokinetic (PK) ...
Engaging in 150 minutes of consistent aerobic weekly exercise may help keep your brain younger, according to recent findings from a study published in the current issue of the Journal of Sport and ...
Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...
In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a second ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it has dosed the first participant ...
Xyngari met all three primary endpoints in the STAR-1 Phase 3 trial, showing a statistically significant improvement in acne severity. Dermata plans to start the STAR-2 Phase 3 trial for Xyngari in H2 ...